Serum cytokine levels towards precision medicine in Still’s disease: a subanalysis of a randomized controlled trial of tocilizumab

Koji Suzuki, Hideto Kameda, Kei Ikeda, Tomonori Ishii, Kosaku Murakami, Hyota Takamatsu, Yoshiya Tanaka, Takayuki Abe, Tsutomu Takeuchi, Yuko Kaneko

Open source

DOI
10.1093/rheumatology/keaf254
Published
2025-06-15
Container
Rheumatology
Publisher
Oxford University Press (OUP)
Open access
unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1093/rheumatology/keaf254,
  title = {Serum cytokine levels towards precision medicine in Still’s disease: a subanalysis of a randomized controlled trial of tocilizumab},
  author = {Koji Suzuki and Hideto Kameda and Kei Ikeda and Tomonori Ishii and Kosaku Murakami and Hyota Takamatsu and Yoshiya Tanaka and Takayuki Abe and Tsutomu Takeuchi and Yuko Kaneko},
  year = {2025},
  journal = {Rheumatology},
  doi = {10.1093/rheumatology/keaf254},
  url = {https://doi.org/10.1093/rheumatology/keaf254}
}

RIS

TY  - JOUR
TI  - Serum cytokine levels towards precision medicine in Still’s disease: a subanalysis of a randomized controlled trial of tocilizumab
AU  - Koji Suzuki
AU  - Hideto Kameda
AU  - Kei Ikeda
AU  - Tomonori Ishii
AU  - Kosaku Murakami
AU  - Hyota Takamatsu
AU  - Yoshiya Tanaka
AU  - Takayuki Abe
AU  - Tsutomu Takeuchi
AU  - Yuko Kaneko
PY  - 2025
JO  - Rheumatology
DO  - 10.1093/rheumatology/keaf254
UR  - https://doi.org/10.1093/rheumatology/keaf254
ER  - 

APA

Suzuki, K., Kameda, H., Ikeda, K., Ishii, T., Murakami, K., Takamatsu, H., Tanaka, Y., Abe, T., Takeuchi, T., & Kaneko, Y. (2025). Serum cytokine levels towards precision medicine in Still’s disease: a subanalysis of a randomized controlled trial of tocilizumab. Rheumatology. https://doi.org/10.1093/rheumatology/keaf254

Source records